Description
41,06,181 equity shares of Camlin Fine Sciences Limited issued at premium to non-promoters on preferential basis pursuant to share swap, listed with effect from January 5, 2026.
Summary
Camlin Fine Sciences Limited (Scrip Code: 532834) has listed 41,06,181 new equity shares of Re.1/- each on BSE with effect from Monday, January 5, 2026. These shares were issued at a premium of Rs.246.69 to non-promoters on a preferential basis pursuant to a share swap arrangement.
Key Points
- 41,06,181 equity shares of Re.1/- each issued
- Issue price: Rs.247.69 per share (Re.1 face value + Rs.246.69 premium)
- Allotted to non-promoters on preferential basis pursuant to share swap
- Shares rank pari-passu with existing equity shares
- Distinctive Numbers: 187980433 to 192086613
- ISIN: INE052I01032
- Date of allotment: November 30, 2025
- All 41,06,181 shares subject to lock-in until July 4, 2026
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
Trading members must note the listing and commencement of trading for these securities from January 5, 2026.
Important Dates
- Date of Allotment: November 30, 2025
- Trading Commencement: Monday, January 5, 2026
- Lock-in Period Ends: July 4, 2026
Impact Assessment
This is a standard listing notification with minimal market impact. The preferential issue increases the equity base by 41.06 lakh shares. The lock-in period until July 4, 2026 ensures these shares cannot be traded for approximately 7 months from the date of allotment, limiting immediate supply impact on the secondary market.
Impact Justification
Routine listing notification for preferential equity shares issued via share swap to non-promoters with standard lock-in period